A novel, long-acting glucagon-like peptide receptor-agonist: dulaglutide
Tara Gurung,1 Deepson S Shyangdan,1 Joseph Paul O’Hare,2 Norman Waugh1 1Warwick Evidence, 2Division of Metabolic and Vascular Health, Warwick Medical School, University of Warwick, Coventry, UK Background: Dulaglutide is a new, long-acting glucagon-like peptide analogue in the treatment of...
Enregistré dans:
| Auteurs principaux: | , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Dove Medical Press
2015
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/bc350032f4514bc8a491ff16d157897f |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|